Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-013328
Filing Date
2019-11-05
Accepted
2019-11-05 16:17:51
Documents
76
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rdus09301910-q.htm   iXBRL 10-Q 1706892
2 EXHIBIT 31.1 rdus09301910qex31d1.htm EX-31.1 11844
3 EXHIBIT 31.2 rdus09301910qex31d2.htm EX-31.2 11821
4 EXHIBIT 32.1 rdus09301910qex32d1.htm EX-32.1 12809
  Complete submission text file 0001628280-19-013328.txt   7478020

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rdus-20190930.xsd EX-101.SCH 47954
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rdus-20190930_cal.xml EX-101.CAL 81780
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rdus-20190930_def.xml EX-101.DEF 234321
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rdus-20190930_lab.xml EX-101.LAB 640953
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rdus-20190930_pre.xml EX-101.PRE 375790
38 EXTRACTED XBRL INSTANCE DOCUMENT rdus09301910-q_htm.xml XML 1359252
Mailing Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451
Business Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451 617-551-4000
Radius Health, Inc. (Filer) CIK: 0001428522 (see all company filings)

EIN.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35726 | Film No.: 191193522
SIC: 2834 Pharmaceutical Preparations